Organon To Be Acquired By Sun Pharma In $11.75B Deal, OGN Stock Spikes Nearly 17% On Robinhood 24-Hour Ma
Summary
Organon & Co. has agreed to be acquired by Sun Pharmaceutical Industries in an all-cash deal valued at $11.75 billion, offering shareholders a 103% premium and marking a major step in Sun Pharma's global expansion into women's health and biosimilars.
Description
Organon & Co. has agreed to be acquired by Sun Pharmaceutical Industries in an all-cash deal valued at $11.75 billion, offering shareholders a 103% premium and marking a major step in Sun Pharma's global expansion into women's health and biosimilars.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source